Clinical trial
Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients
NCT00428025 · Queen's University, Other · Terminated
Key facts
| NCT number | NCT00428025 |
|---|---|
| Title | Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients |
| Official title | Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients: A Prospective, Randomized, Double Blind, Placebo Controlled Trial. |
| Lead sponsor | Queen's University, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pancreatitis |
| Intervention type | Drug |
| Interventions | diclofenac, placebo |
| Enrollment | 23 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Sep 22, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: